TY - JOUR
T1 - The use of preoperative intra-aortic balloon pump in open heart surgery
AU - Pfeiffer, S.
AU - Frisch, P.
AU - Weyand, M.
AU - Ensminger, S. M.
AU - Tandler, R.
AU - Sirch, J.
AU - Fischlein, T.
AU - Cesnjevar, R.
PY - 2005
Y1 - 2005
N2 - Aim. Intra-aortic balloon pump (IABP) therapy before open heart surgery has been suggested for "high risk" patients. Methods. Records from patients undergoing open heart surgery at our institution between June 1999 and February 2002 were reviewed. Indication for IABP insertion was severely impaired left ventricular function, acute myocardial infarction (MI) or unstable angina. Results. Fifthy-five patients were included in the study: 41 male, 14 female, age 64±9 years. Fifthy-one (92.7%) required coronary artery bypass brafting (CABG) alone or as a combined procedure, 2 (3.6%) required mitral valve surgery, and 2 (3.6%) needed more complex cardiac procedures. Thirty-two patients (58%) underwent emergency cardiac surgery and 11 patients (20%) suffered from acute preoperative MI. The overall 30 days mortality was 9%. Mean intensive care unit (ICU) stay was 6±8 days. Four patients (7.2%) developed postoperative renal failure requiring temporary hemodialysis. Three patients (5.4%) developed IABP related peripheral vascular complications. Conclusion. Perioperative morbidity and mortality is increased despite preoperative IABP, particularly in patients with acute MI. In contrast to studies not using this approach, preoperative IABP reduces morbidity and mortality of high risk patients. IABP related complications are low. Our data suggest that high risk patients profit from preoperative IABP therapy, however, prospective studies are needed to confirm these findings.
AB - Aim. Intra-aortic balloon pump (IABP) therapy before open heart surgery has been suggested for "high risk" patients. Methods. Records from patients undergoing open heart surgery at our institution between June 1999 and February 2002 were reviewed. Indication for IABP insertion was severely impaired left ventricular function, acute myocardial infarction (MI) or unstable angina. Results. Fifthy-five patients were included in the study: 41 male, 14 female, age 64±9 years. Fifthy-one (92.7%) required coronary artery bypass brafting (CABG) alone or as a combined procedure, 2 (3.6%) required mitral valve surgery, and 2 (3.6%) needed more complex cardiac procedures. Thirty-two patients (58%) underwent emergency cardiac surgery and 11 patients (20%) suffered from acute preoperative MI. The overall 30 days mortality was 9%. Mean intensive care unit (ICU) stay was 6±8 days. Four patients (7.2%) developed postoperative renal failure requiring temporary hemodialysis. Three patients (5.4%) developed IABP related peripheral vascular complications. Conclusion. Perioperative morbidity and mortality is increased despite preoperative IABP, particularly in patients with acute MI. In contrast to studies not using this approach, preoperative IABP reduces morbidity and mortality of high risk patients. IABP related complications are low. Our data suggest that high risk patients profit from preoperative IABP therapy, however, prospective studies are needed to confirm these findings.
UR - http://www.scopus.com/inward/record.url?scp=19844368744&partnerID=8YFLogxK
M3 - Scientific review articles
C2 - 15758879
AN - SCOPUS:19844368744
SN - 0021-9509
VL - 46
SP - 55
EP - 60
JO - Journal of Cardiovascular Surgery
JF - Journal of Cardiovascular Surgery
IS - 1
ER -